image
ACADIA Pharmaceuticals Inc. ACAD
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 16.77
-1.47 %
$ 2.79 B
Market Cap
22.07
P/E
CASH FLOW STATEMENT
16.7 M OPERATING CASH FLOW
114.65%
Growth Rates
1Year 114.65%
3Years 28.52%
5Years 15.99%
7Years 11.02%
10Years 9.71%
32 M INVESTING CASH FLOW
-56.31%
Growth Rates
1Year -56.31%
3Years -45.02%
5Years 19.60%
7Years 11.35%
10Years 8.47%
25.1 M FINANCING CASH FLOW
206.49%
Growth Rates
1Year 206.49%
3Years -32.30%
5Years -39.37%
7Years -35.38%
10Years -13.86%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis ACADIA Pharmaceuticals Inc.
image
Net Income -61.3 M
Depreciation & Amortization 5.55 M
Capital Expenditures -40 M
Stock-Based Compensation 66.4 M
Change in Working Capital 18.1 M
Others 210 M
Free Cash Flow -23.3 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2000
OPERATING CASH FLOW
Net Income (61.3) (216.0) (167.9) (281.6) (235.3) (245.2) (289.4) (271.4) (164.4) (92.5) (37.9) (20.8) (22.8) 15.1 (45.1) (64.2) (56.4) (45.0) (34.1) (25.9) (14.1) (12.9) (10.2)
Depreciation & Amortization 5.6 2.0 3.3 2.9 2.8 3.0 2.7 1.8 0.6 0.2 79 K 0.1 0.3 0.6 1.1 1.0 0.8 (0.1) 1.0 1.3 1.3 1.4 0
Deferred Income Tax (140.8) 0 0 2.7 0 0 0 (0.6) (0.2) 0 0 0 0.1 0 0 0.9 (3.5) (3.6) (1 307.7) (2 355.8) 0 0 0
Stock Based Compensation 66.4 68.2 63.6 84.4 82.3 81.6 75.5 55.3 40.2 16.0 5.7 1.9 1.6 1.6 2.1 3.0 3.4 3.4 1 307.7 2 355.8 0 0 0
Other Operating Activities 128.7 (6.3) 75 K 44.3 (4.6) 1.4 (0.3) 94 K (2.1) 0.5 1.5 (0.4) 0.8 (0.2) 0.6 5 K 4.3 3.4 1.5 2.4 1.4 1.2 (15.1)
Change in Working Capital 18.1 38.0 (24.8) 11.0 3.7 (8.2) (6.4) 4.4 4.1 9.3 (1.1) (2.4) 74 K (27.8) 27.6 (5.6) (3.4) 0.6 11.4 1.6 1.5 1.1 25.3
Cash From Operations 16.7 (114.0) (125.7) (136.2) (151.1) (167.5) (217.9) (210.4) (121.8) (66.4) (31.8) (21.6) (19.9) (10.7) (13.7) (64.9) (54.9) (41.4) (20.3) (20.7) (9.8) (9.2) 0
INVESTING CASH FLOW
Capital Expenditures (40.0) 0 (1.1) (7.6) (1.1) (2.1) (0.8) (9.5) (2.1) (0.2) (0.6) 3 K 3 K 0 41 K (0.2) (0.4) (2.0) (1.0) (0.6) (1.8) (0.4) 0
Other Items 72.0 73.2 (70.0) 200.1 (164.7) (69.3) 93.3 (252.4) 149.7 (87.1) (125.5) (25.5) 6.0 (1.1) 9.5 69.9 (41.5) (20.9) (5.6) (6.8) (12.9) 4.2 0
Cash From Investing Activities 32.0 73.2 (71.1) 192.5 (165.8) (71.5) 92.5 (261.9) 147.6 (87.3) (126.1) (25.5) 6.0 (1.1) 9.4 69.7 (41.9) (22.9) (6.7) (7.4) (14.7) 3.8 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0 0 0 0 0 0 0 0 32 K 78 K (0.4) (0.8) (0.9) (0.4) 0.6 (0.8) (1.4) (1.6) 4.4 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0 0 0 14.9 45 K 0 0 0 0 0 0 0 0 0 (12.5) 0 0 0 0
Cash From Financing Activities 25.1 8.2 18.2 81.0 371.8 306.6 31.2 533.8 14.5 203.9 111.7 98.2 13.9 0.5 1.2 (0.4) 98.2 70.0 28.4 30.1 26.4 4.4 0
CHANGE IN CASH
Net Change In Cash 73.8 (32.6) (178.6) 137.3 54.9 67.7 (94.2) 61.5 40.3 50.1 (46.2) 51.0 40 K (11.3) (3.0) 4.2 1.5 5.7 1.5 2.0 1.9 (1.1) 0
FREE CASH FLOW
Free Cash Flow (23.3) (114.0) (126.8) (143.8) (152.3) (169.6) (218.7) (219.9) (123.9) (66.6) (32.4) (21.6) (19.9) (10.7) (13.8) (65.1) (55.3) (43.4) (21.3) (21.3) (11.6) (9.6) 0